Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Epidermal growth factor receptor mutations and radiotherapy in non-small cell lung cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 1 Mar 2013

Zhong Xing, Wang Jin

Abstract excerpt

Radiotherapy plays a pivotal role in the treatment for lung cancer. Epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC) which predicts tyrosine kinase inhibitor (TKI) treatment response may also has effect on radiation response. NSCLC harboring kinase-domain mutations in EGFR exhibits enhanced radio-sensitivity due to dramatically diminished capacity to resolve radiation-induced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Cell Line, Tumor
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to EGFR gene

Share to Lung Neoplasms

Share to Mutation

Share to Protein Kinase Inhibitors

Share to Radiation Tolerance

Source

Open in PubMed Open full text

Identifiers

PMID: 23514946
DOI: 10.3779/j.issn.1009-3419.2013.03.08
PMCID: PMC6015137

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Epidermal growth factor receptor mutations and radiotherapy in non-small cell lung cancer].PMID 23514946Read ↗

Radiotherapy of non-small-cell lung cancer in the era of EGFR gene mutations and EGF receptor tyrosine kinase inhibitors.Semantic proximity Read ↗

[EGFR-mutation in non-small cell lung carcinoma. Treatment with tyrosine kinase inhibitors possible].Semantic proximity Read ↗

[Targeted therapy in EGFR-mutated lung cancer following chemoradiotherapy].Semantic proximity Read ↗

[Role of EGFR mutation status in patients with stage III non-squamous non-small cell lung cancer treated with chemoradiotherapy].Semantic proximity Read ↗

[Ionizing Radiation Reduces TKI Resistance Caused by T790M Mutation in NSCLC Cell Lines].Semantic proximity Read ↗

Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation.Semantic proximity Read ↗

[Molecular targeted therapy--non-small-cell lung cancer and gefitinib].Semantic proximity Read ↗

Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower DosesSemantic proximity Read ↗

[Gefitinib and epidermal growth factor receptor gene mutation].Semantic proximity Read ↗

The EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells.Semantic proximity Read ↗

Tumor response to radiotherapy and expression of epidermal growth factor receptor mutation and echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase rearrangement in patients with non-small cell lung cancer.Semantic proximity Read ↗

Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non-Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.